Although current evidence supports broad applicability across BMI, diabetes status, and fibrosis stages F2-F3, subgroup analyses suggest attenuated responses in non-obese patients and in certain ethnic groups (Hispanic patients in ESSENCE), emphasizing the need for precision medicine approaches incorporating anthropometric, genetic (e.g., PNPLA3, HSD17B13), and metabolic profiling
The drastic inhibition of GLP-1 secretion via shutdown of the main pathway is the primary cause of pasireotide-induced hyperglycemia
Circulating and locally produced IGF-1 mediates many of GHs downstream effects and also feeds back negatively on both the hypothalamus and pituitary to restrain further GH release
Popping a flavorful gummy is easier than swallowing pills or mixing a powder into a drink
Invalid data format causes failures
Mod GRF 1-29 and Pituitary Pathways Mod GRF 1-29 has been studied for its possible binding to GHRH receptors on pituitary cells